Gradient Denervation Technologies announced that it closed a $15 million (€14 million) Series A financing round.
Paris-based Gradient develops a catheter-based solution for treating pulmonary hypertension. It expects the financing to support the ongoing clinical development and evaluation of the ultrasound-based device.
Asabys Partners led the round through its new fund, Sabadell Asabys II. Thuja Capital and founding investor Sofinnova Partners also participated in the round.
Gradient designed its novel technology to treat pulmonary hypertension by reducing sympathetic input into the pulmonary vasculature.
Get the full story at our sister site, Medical Tubing & Extrusion.
